Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

about

Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review.

P2860

Q33815262-34A98650-EF23-4BC5-AD8E-BC1300D930A6 Q54214331-D947F347-D71F-49FE-A0FF-FA1F5E1F92D4

P2860

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

Item

http://www.wikidata.org/entity/Q39029592

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

@en

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

@nl

type

Item

label

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

@en

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

@nl

prefLabel

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

@en

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

@nl

P1476

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

@en

P2093

Simon Francis Thomsen

http://www.w3.org/2001/XMLSchema#string

Tamara Lund

http://www.w3.org/2001/XMLSchema#string

P2860

Definition of treatment goals for moderate to severe psoriasis: a European consensus

Correlations between psoriasis and inflammatory bowel diseases

Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.

Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.

Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Is infliximab safe to use while breastfeeding?

Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature.

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.

Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature.

Psoriasis in pregnancy: a review (I).

P31

scholarly article

P356

10.1111/DTH.12454

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28071837

http://www.w3.org/2001/XMLSchema#string

P921

TNF

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

about

P2860

P2860

Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921